Patents by Inventor Hamiduddin Khoja

Hamiduddin Khoja has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROTEIN AND METABOLITE ENRICHMENT USING FOCUSED ACOUSTIC ENERGY
    Publication number: 20220299498
    Abstract: Apparatus and method for disassociating protein complexes, e.g., to allow recovery and/or analysis of at least one of the proteins or metabolites released from a complex. Disassociation is done using focused acoustic energy and without solvents, excessive heat or other process conditions that damage proteins or metabolites. Disassociation may be followed by depletion of one of the proteins released from complexes, e.g., to allow another protein or metabolite released from the complexes to be recovered.
    Type: Application
    Filed: March 21, 2022
    Publication date: September 22, 2022
    Applicant: Covaris, LLC
    Inventors: James A. Laugharn, JR., Ulrich Thomann, Nicolas Alexandre Julien Autret, Eugenio Daviso, Hamiduddin Khoja
  • HX2004-6 polypeptide expressed in cancerous cells
    Patent number: 7867731
    Abstract: The present invention provides polynucleotides, as well as polypeptides encoded thereby, that are differentially expressed in cancer cells. These polynucleotides are useful in a variety of diagnostic and therapeutic methods. The present invention further provides methods of reducing growth of cancer cells. These methods are useful for treating cancer.
    Type: Grant
    Filed: October 28, 2004
    Date of Patent: January 11, 2011
    Assignee: Novartis Vaccines and Diagnostics, Inc.
    Inventors: Christoph Reinhard, Anne Bennett Jefferson, Vivien W. Chan, Joerg Kaufmann, Hong Xin, Giulia C. Kennedy, Greg Harrowe, Hamiduddin Khoja, Venkatakrishna Shyamala
  • Gene products differentially expressed in cancerous cells and their methods of use V
    Publication number: 20050130926
    Abstract: The present invention provides polynucleotides, as well as polypeptides encoded thereby, that are differentially expressed in cancer cells. These polynucleotides are useful in a variety of diagnostic and therapeutic methods. The present invention further provides methods of reducing growth of cancer cells. These methods are useful for treating cancer.
    Type: Application
    Filed: October 28, 2004
    Publication date: June 16, 2005
    Inventors: Christoph Reinhard, Anne Jefferson, Vivien Chan, Joerg Kaufmann, Hong Xin, Giulia Kennedy, Greg Harrowe, Hamiduddin Khoja, Venkatakrishna Shyamala
  • Isolated VSHK-1 receptor polypeptides and methods of use thereof
    Publication number: 20050059801
    Abstract: A new seven transmembrane receptor has been identified, and the amino acid and nucleotide sequence of the receptor are provided. The nucleotide sequence is useful to construct expression cassettes and vectors to produce host cells which are capable of expressing the receptor, its mutants, fragments, or fusions. Such polypeptides are useful for identifying new receptor binding agonists and antagonists.
    Type: Application
    Filed: October 30, 2003
    Publication date: March 17, 2005
    Inventors: Hamiduddin Khoja, Venkatarkrishna Shyamala